Literature DB >> 22196155

Acid phosphatase-positive globular inclusions is a good diagnostic marker for two patients with adult-onset Pompe disease lacking disease specific pathology.

Rie S Tsuburaya1, Kazunari Monma, Yasushi Oya, Takahiro Nakayama, Tokiko Fukuda, Hideo Sugie, Yukiko K Hayashi, Ikuya Nonaka, Ichizo Nishino.   

Abstract

Diagnosis of adult-onset Pompe disease is sometimes challenging because of its clinical similarities to muscular dystrophy and the paucity of disease-specific vacuolated fibers in the skeletal muscle pathology. We describe two patients with adult-onset Pompe disease whose muscle pathology showed no typical vacuolated fibers but did show unique globular inclusions with acid phosphatase activity. The acid phosphatase-positive globular inclusions may be a useful diagnostic marker for adult-onset Pompe disease even when typical vacuolated fibers are absent.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22196155     DOI: 10.1016/j.nmd.2011.11.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  11 in total

1.  Therapeutic advances in the management of Pompe disease and other metabolic myopathies.

Authors:  Corrado Angelini; Anna Chiara Nascimbeni; Claudio Semplicini
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

Review 2.  Pompe Disease: From Basic Science to Therapy.

Authors:  Lara Kohler; Rosa Puertollano; Nina Raben
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

3.  Diagnostic value of acid phosphatases (ACP) in differentiating reactive mesothelial cells from cancer cells in the body fluid effusions.

Authors:  Yun-Hui Li; Yang Wang; Xiu-Xia Chen; Bin Liang; Xue-Shan Qiu; En-Hua Wang; Guang-Ping Wu
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

4.  The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients.

Authors:  Erin J Feeney; Stephanie Austin; Yin-Hsiu Chien; Hanna Mandel; Benedikt Schoser; Sean Prater; Wuh-Liang Hwu; Evelyn Ralston; Priya S Kishnani; Nina Raben
Journal:  Acta Neuropathol Commun       Date:  2014-01-02       Impact factor: 7.801

5.  Familial adult-onset Pompe disease associated with unusual clinical and histological features.

Authors:  Lorenzo Maggi; Franco Salerno; Cinzia Bragato; Simona Saredi; Flavia Blasevich; Elio Maccagnano; Barbara Pasanisi; Cesare Danesino; Marina Mora; Lucia Morandi
Journal:  Acta Myol       Date:  2013-10

Review 6.  Pompe disease: from pathophysiology to therapy and back again.

Authors:  Jeong-A Lim; Lishu Li; Nina Raben
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

7.  Myoglobinopathy is an adult-onset autosomal dominant myopathy with characteristic sarcoplasmic inclusions.

Authors:  Montse Olivé; Martin Engvall; Gianina Ravenscroft; Macarena Cabrera-Serrano; Hong Jiao; Carlo Augusto Bortolotti; Marcello Pignataro; Matteo Lambrughi; Haibo Jiang; Alistair R R Forrest; Núria Benseny-Cases; Stefan Hofbauer; Christian Obinger; Gianantonio Battistuzzi; Marzia Bellei; Marco Borsari; Giulia Di Rocco; Helena M Viola; Livia C Hool; Josep Cladera; Kristina Lagerstedt-Robinson; Fengqing Xiang; Anna Wredenberg; Francesc Miralles; Juan José Baiges; Edoardo Malfatti; Norma B Romero; Nathalie Streichenberger; Christophe Vial; Kristl G Claeys; Chiara S M Straathof; An Goris; Christoph Freyer; Martin Lammens; Guillaume Bassez; Juha Kere; Paula Clemente; Thomas Sejersen; Bjarne Udd; Noemí Vidal; Isidre Ferrer; Lars Edström; Anna Wedell; Nigel G Laing
Journal:  Nat Commun       Date:  2019-03-27       Impact factor: 14.919

8.  Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease.

Authors:  Anastasia Godefroy; Morgane Daurat; Afitz Da Silva; Ilaria Basile; Khaled El Cheikh; Catherine Caillaud; Sabrina Sacconi; Benedikt Schoser; Henry-Vincent Charbonné; Magali Gary-Bobo; Alain Morère; Marcel Garcia; Marie Maynadier
Journal:  J Cell Mol Med       Date:  2019-07-10       Impact factor: 5.310

9.  Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy.

Authors:  Sean N Prater; Trusha T Patel; Anne F Buckley; Hanna Mandel; Eugene Vlodavski; Suhrad G Banugaria; Erin J Feeney; Nina Raben; Priya S Kishnani
Journal:  Orphanet J Rare Dis       Date:  2013-06-20       Impact factor: 4.123

10.  Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins.

Authors:  Camilo Toro; Montse Olivé; Marinos C Dalakas; Kumaraswami Sivakumar; Juan M Bilbao; Felix Tyndel; Noemí Vidal; Eva Farrero; Nyamkhishig Sambuughin; Lev G Goldfarb
Journal:  BMC Neurol       Date:  2013-03-20       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.